Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sekisui Chemical Of Japan To Increase Overseas Diagnostic Agent Sales

This article was originally published in PharmAsia News

Executive Summary

Sekisui Chemical plans to increase overseas diagnostic agent sales from its current 20 percent to 30 percent in 2013. Last year, the top Japanese diagnostic maker acquired U.S. companies Xenotech and American Diagnostics. Sekisui plans to expand Xenotech's pharmacokinetics business and ADI's DVV line of diagnostic tests, which detect specific antibodies related to conditions associated with lupus anticoagulants. Five core areas identified by the company are: LDL/HDL testing agents, anticoagulants, diabetes, infection and advanced technology. (Click here for more - Japanese Language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts